by Annie De Groot | Jun 29, 2019 | Events
Updated: Thank you to those that joined us for the seminar! It was a successful meeting with many wonderful talks. Please find photos from the event here as well as slide decks from some of our speakers. Welcome to Immunogenicity and Tolerance; Anne De Groot...
by Annie De Groot | Jun 28, 2019 | Events
25th Annual International Partnering Conference BIO-Europe Monday, November 11th – Wednesday, November 13th Hamburg Messe East Entrance Hamburg, Germany Network with EpiVax’s Business Development Manager, Katie Porter, and European Representative, Paul Von...
by Adam | Dec 29, 2018 | News
EpiVax Re-Pledges Commitment to Improving [Human] Health Everywhere Providence, R.I., December 28th, 2018 EpiVax, Inc. is once more pledging to fulfill its mission to “improve human health everywhere”. The employees of this Providence-based, privately-owned...
by Sarah Moniz | Sep 26, 2018 | Events
UPDATE: Here are commemorative photos from our event. Thank you to all the speakers and participants for making the 2018 seminar a success. See you next year! The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas,...
by Sarah Moniz | Jun 13, 2018 | News
NEW YORK CITY AND PROVIDENCE, RI., June 12, 2018 (BUSINESS WIRE) — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced the closing of a $1.2M Bridge Financing. The investors include NextWaveBio, Morningside Venture Investments, Accelerate...
